Coliseum Capital Management, LLC sold 3.0 million shares for a transaction value of $124.2 million on June 8, 2026.
This sale represented 76% of its total holdings, reducing ownership from 3,971,440 to 971,440 shares.
All shares sold were held indirectly through Coliseum Capital Partners, L.P. and a separate account, with no direct ownership involved.
Coliseum's Christopher S. Shackleton has sat on the board of directors of UTI since June 2016.
Long-time investor Coliseum Capital Management, which also has a seat on the board of directors, sold most of its position in Universal Technical Institute (NYSE:UTI) on June 8. The asset manager sold 3.0 million shares of Common Stock at $41.40 per share, according to a SEC Form 4 filing.
Is this a signal for other investors to sell?
| Metric | Value |
|---|---|
| Shares sold (indirect) | 3,000,000 |
| Transaction value | $124.2 million |
| Post-transaction shares (direct) | 0 |
| Post-transaction shares (indirect) | 971,440 |
| Post-transaction value (direct ownership) | $0 |
Transaction value based on SEC Form 4 reported price ($41.40).
| Metric | Value |
|---|---|
| Revenue (TTM) | $868,986,000.00 |
| Net income (TTM) | $42,679,000.00 |
| Employees | 3,700 |
| 1-year price change | 18.57% |
* 1-year price change calculated as of June 12, 2026.
Universal Technical Institute, Inc. is a leading provider of technical education and workforce training in the United States, operating multiple campuses and specialized institutes. The company leverages a diversified curriculum and partnerships with industry manufacturers to maintain relevance and demand for its graduates. Its scale and focus on high-demand skilled trades position it competitively within the education and training services sector.
There are reasons insiders may sell shares in a company that have little to do with their view of the company’s fortunes. But it’s hard to look at Coliseum Capital’s sale of Universal Technical Institute stock as anything but bearish.
Coliseum invested in UTI in 2016 in a private transaction that gave the firm some shares at $2.71 and the right to convert a loan it provided into equity at a series of higher prices. Coliseum clearly converted its debt into a large number of shares in the trade school business over the past decade and was sitting on a healthy profit of many millions of dollars. By virtue of its large ownership stake in UTI, the company also had a seat on the board of directors.
On one hand, a hedge fund like Coliseum wants to eventually lock in profits on an investment, especially after 10 years since its initial investment in Universal Technical Institute. This sale may not mean Coliseum is exactly bearish on UTI, but it certainly isn’t a signal that the firm continues to see UTI as a better growth prospect than other investments it can make.
Seeing a long-time, significant shareholding insider sell out the vast majority of their position like this should be a signal for other investors in UTI to reconsider their investment rationale for the company and whether they should remain invested.
Before you buy stock in Universal Technical Institute, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Universal Technical Institute wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $433,268!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,259,391!*
Now, it’s worth noting Stock Advisor’s total average return is 935% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of June 13, 2026.
Brendan Coffey has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.